Nearly 30% of Sonida (NYSE: SNDA) now tied to one fund group

Rhea-AI Filing Summary

SONIDA SENIOR LIVING, INC. (SNDA) is the subject of this Amendment No. 10 to a Schedule 13D, updating the ownership position of Conversant Capital LLC and affiliated funds and entities in the company’s common stock.

Conversant Capital and related reporting persons collectively report 14,454,529 shares of SNDA common stock (including 1,031,250 shares issuable upon exercise of issuer warrants), representing 29.5% of the common stock, based on 48,047,990 outstanding shares as of August 7, 2026 plus those warrants. Individual affiliated entities report stakes ranging from about 0.5% to 21.1%, all with shared voting and dispositive power. On August 21, 2026, CPIF Sparti SAF, L.P. distributed in kind an aggregate 1,182,595 SNDA shares to certain limited partners unaffiliated with Conversant Capital, for no consideration, in connection with their withdrawal from that fund. Conversant Capital maintains a non-discretionary investment advisory relationship and an ongoing interest in proceeds from sales of distributed shares held by one distributee, subject to an agreed hurdle rate.

Key Figures

Beneficial ownership by Conversant Capital LLC: 14,454,529 shares (29.5%) Shares outstanding: 48,047,990 shares Warrant shares held by Conversant Dallas Parkway (A) and (B): 1,031,250 shares +5 more

8 metrics

Beneficial ownership by Conversant Capital LLC 14,454,529 shares (29.5%) Includes 1,031,250 SNDA shares issuable upon exercise of warrants

Shares outstanding 48,047,990 shares SNDA common shares outstanding as of August 7, 2026

Warrant shares held by Conversant Dallas Parkway (A) and (B) 1,031,250 shares SNDA common shares issuable upon exercise of issuer warrants

In-kind distribution from CPIF Sparti SAF, L.P. 1,182,595 shares SNDA common shares distributed to certain limited partners on August 21, 2026

Beneficial ownership by Conversant GP Holdings LLC 10,377,346 shares (21.1%) Includes 1,031,250 SNDA shares issuable upon exercise of warrants

Beneficial ownership by Conversant Dallas Parkway (A) LP 7,826,361 shares (15.9%) Includes 968,538 SNDA shares issuable upon exercise of warrants

Beneficial ownership by Conversant PIF Aggregator A LP 3,199,998 shares (6.5%) All SNDA common shares with shared voting and dispositive power

Beneficial ownership by CPIF K Co-Invest SPT A, L.P. 224,829 shares (0.5%) SNDA common shares with shared voting and dispositive power

Key Terms

beneficially owned, shared voting power, shared dispositive power, in kind, +2 more

6 terms

beneficially owned financial

"Aggregate amount beneficially owned by each reporting person 14,454,529.00"

Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.

shared voting power financial

"Shared Voting Power 14,454,529.00"

Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.

shared dispositive power financial

"Shared Dispositive Power 14,454,529.00"

in kind financial

"CPIF SAF to distribute in kind an aggregate 1,182,595 shares"

Payment, distribution, or transfer made with assets or goods rather than cash, such as shares, property, bonds, or inventory. It matters to investors because receiving or giving value in kind affects liquidity, valuation, record-keeping, and tax treatment—similar to getting a basket of apples instead of cash for a tree: you own something real but may need to convert, value, or manage it differently than money.

investment advisory relationship financial

"Conversant Capital has a non-discretionary investment advisory relationship"

hurdle rate financial

"subject in respect of the latter to an agreed-upon hurdle rate"

The hurdle rate is the minimum annual return an investment must be expected to deliver before it is considered worthwhile. Think of it as the height of a jump: if a project or asset can’t clear that height, capital is kept elsewhere. For investors, the hurdle rate acts as a simple pass/fail benchmark that guides buy/sell decisions, risk assessment and how future cash flows are valued.

FAQ

How much of SONIDA SENIOR LIVING, INC. (SNDA) does Conversant Capital now beneficially own?

Conversant Capital LLC and related reporting persons report beneficial ownership of 14,454,529 SNDA common shares, including 1,031,250 shares issuable upon exercise of warrants, representing 29.5% of the company’s common stock as calculated in the filing.

What event triggered this Amendment No. 10 to the Schedule 13D for SNDA?

On August 21, 2026, CPIF Sparti SAF, L.P. distributed in kind an aggregate 1,182,595 SNDA common shares to certain limited partners unaffiliated with Conversant Capital, for no consideration, in connection with their withdrawal from the fund. This distribution led to the updated disclosure.

What share count and warrants are used to calculate Conversant’s 29.5% stake in SNDA?

The 29.5% ownership is based on 48,047,990 SNDA common shares outstanding as of August 7, 2026, plus 1,031,250 common shares issuable upon exercise of issuer warrants held by Conversant Dallas Parkway (A) LP and (B) LP, as described in the filing.

Which Conversant-related entity holds the largest individual stake in SNDA?

Conversant Capital LLC itself reports beneficial ownership of 14,454,529 SNDA common shares (including 1,031,250 warrant shares), equal to 29.5% of the common stock, with 14,454,529 shares subject to shared voting and shared dispositive power.

What are some of the other notable ownership positions in SNDA by Conversant affiliates?

Conversant GP Holdings LLC reports 10,377,346 shares (21.1%); Conversant Dallas Parkway (A) LP reports 7,826,361 shares (15.9%); Conversant PIF Aggregator A LP reports 3,199,998 shares (6.5%); and Conversant Private GP LLC reports 4,077,183 shares (8.3%), all with shared voting and dispositive power.

Does Conversant Capital retain any interest in the SNDA shares distributed from CPIF Sparti SAF, L.P.?

Yes. Conversant Capital has a non-discretionary investment advisory relationship with one distributee and an ongoing interest in the proceeds of sales of that distributee’s distributed SNDA shares, subject to an agreed-upon hurdle rate.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/25/2026 - 09:18 AM Accepted by SEC EDGAR 08/25/2026 - 09:17 AM Learn about SEC filing dates

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 10)

SONIDA SENIOR LIVING, INC.

(Name of Issuer)

Common Stock, $0.01 par value per share

(Title of Class of Securities)

140475203

(CUSIP Number)

Conversant Capital LLC
25 Deforest Avenue, Attn: Paul Dumaine
Summit, NJ, 07901
908-466-5050

With a copy to: John M. Bibona
Fried,Frank,Harris,Shriver&Jacobson LLP, One New York Plaza
New York, NY, 10004
(212) 859-8000

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)

08/21/2026

(Date of Event Which Requires Filing of This Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

schemaVersion:

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant Dallas Parkway (A) LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 7,826,361.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 7,826,361.00

11

Aggregate amount beneficially owned by each reporting person

7,826,361.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

15.9 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 6,857,823 shares of Common Stock, and (ii) 968,538 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant Dallas Parkway (B) LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 869,827.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 869,827.00

11

Aggregate amount beneficially owned by each reporting person

869,827.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

1.8 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 807,115 shares of Common Stock, and (ii) 62,712 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant Dallas Parkway (D) LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 1,032,216.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 1,032,216.00

11

Aggregate amount beneficially owned by each reporting person

1,032,216.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

2.1 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 1,032,216 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant Dallas Parkway (F) LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 648,942.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 648,942.00

11

Aggregate amount beneficially owned by each reporting person

648,942.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

1.3 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 648,942 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant PIF Aggregator A LP

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 3,199,998.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 3,199,998.00

11

Aggregate amount beneficially owned by each reporting person

3,199,998.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

6.5 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 3,199,998 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant GP Holdings LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 10,377,346.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 10,377,346.00

11

Aggregate amount beneficially owned by each reporting person

10,377,346.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

21.1 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 9,346,096 shares of Common Stock, and (ii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant Capital LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,454,529.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,454,529.00

11

Aggregate amount beneficially owned by each reporting person

14,454,529.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

29.5 %

14

Type of Reporting Person (See Instructions)

IA, OO

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 13,423,279 shares of Common Stock, and (ii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Conversant Private GP LLC

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 4,077,183.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 4,077,183.00

11

Aggregate amount beneficially owned by each reporting person

4,077,183.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

8.3 %

14

Type of Reporting Person (See Instructions)

OO

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 4,077,183 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

CPIF K Co-Invest SPT A, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

CAYMAN ISLANDS

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 224,829.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 224,829.00

11

Aggregate amount beneficially owned by each reporting person

224,829.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

0.5 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 224,829 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

CPIF Sparti SAF, L.P.

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 652,356.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 652,356.00

11

Aggregate amount beneficially owned by each reporting person

652,356.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

1.3 %

14

Type of Reporting Person (See Instructions)

PN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the aggregate of 652,356 shares of Common Stock. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

CUSIP Number(s): 140475203

1

Name of reporting person

Simanovsky Michael

2

Check the appropriate box if a member of a Group (See Instructions)

(a)
(b)

3

SEC use only

4

Source of funds (See Instructions)

OO

5

Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

6

Citizenship or place of organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

7	Sole Voting Power 0.00
8	Shared Voting Power 14,454,529.00
9	Sole Dispositive Power 0.00
10	Shared Dispositive Power 14,454,529.00

11

Aggregate amount beneficially owned by each reporting person

14,454,529.00

12

Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)

13

Percent of class represented by amount in Row (11)

29.5 %

14

Type of Reporting Person (See Instructions)

IN

Comment for Type of Reporting Person:

(1) The shared voting and dispositive power identified in rows (8) and (10), and the aggregate amount of shares identified as beneficially owned in row (11), each reflect the sum of (i) 13,423,279 shares of Common Stock, and (ii) 1,031,250 shares of Common Stock issuable upon exercise of warrants of the Issuer. (2) The percentage reflected in row (13) is calculated based on the sum of (i) 48,047,990 outstanding shares of Common Stock on August 7, 2026, as disclosed in the Amendment to the Form S-3 filed by the Issuer with the Commission on August 10, 2026, plus (ii) 1,031,250 shares of Common Stock issuable in the aggregate upon exercise of the Issuer warrants held by Conversant Dallas Parkway (A) LP and Conversant Dallas Parkway (B) LP.

SCHEDULE 13D

Item 1.	Security and Issuer
(a)	Title of Class of Securities: Common Stock, $0.01 par value per share
(b)	Name of Issuer: SONIDA SENIOR LIVING, INC.
(c)	Address of Issuer's Principal Executive Offices: 14755 PRESTON ROAD, SUITE 810, DALLAS, TEXAS , 75254.
Item 1 Comment: This Amendment No. 10 ("Amendment No. 10") further amends and supplements the original statement on Schedule 13D filed by Conversant Dallas Parkway (A) LP ("Investor A"), Conversant Dallas Parkway (B) LP ("Investor B"), Conversant GP Holdings LLC ("Conversant GP"), Conversant Capital LLC ("Conversant Capital"), and Michael J. Simanovsky on November 12, 2021 (the "Original Schedule 13D"), as previously amended by them by the amended statement on Schedule 13D filed on August 10, 2026 ("Amendment No. 9"), Amendment No. 8 filed on March 13, 2026, Amendment No. 7 filed on November 5, 2025, Amendment No. 6 filed on October 17, 2024, Amendment No. 5 filed on August 21, 2024, Amendment No. 4 filed on March 26, 2024, Amendment No. 3 filed on February 6, 2024, Amendment No. 2 filed on November 6, 2023 and Amendment No. 1 filed on July 7, 2023. Amendment No. 4 was the initial statement on Schedule 13D for Conversant Dallas Parkway (D) LP ("Investor D") regarding the Issuer. Amendment No. 5 was the initial statement on Schedule 13D for Conversant PIF Aggregator A LP ("Aggregator A"), and Conversant Private GP LLC ("Conversant Private GP") regarding the Issuer. Amendment No. 6 was the initial statement on Schedule 13D for Conversant Dallas Parkway (F) LP ("Investor F") regarding the Issuer. Amendment No. 8 was the initial statement on Schedule 13D for CPIF K Co-Invest SPT A, L.P. ("CPIF K") and CPIF Sparti SAF, L.P. ("CPIF SAF"). Investor A, Investor B, Investor D, Aggregator A, Investor F, CPIF K and CPIF SAF together are the "Conversant Investors," and they, together with Conversant GP, Conversant Capital, Conversant Private GP and Mr. Simanovsky are the "Reporting Persons." The Original Schedule 13D, as previously amended, remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 10, provided that with respect to any Item amended herein, if such Item is incorporated by reference into any other Item in the Original Schedule 13D, as previously amended, such incorporation by reference is also amended hereby. Capitalized terms used and not defined in this Amendment No. 10 have the meanings set forth in the Original Schedule 13D, as previously amended.
Item 3.	Source and Amount of Funds or Other Consideration
	Item 3 of the Original Schedule 13D, as previously amended, is hereby amended to incorporate the following. On August 21, 2026, at the request of certain limited partners of CPIF SAF unaffiliated with Conversant Capital, and in satisfaction of Conversant Private GP's pre-existing obligations to such limited partners, Conversant Private GP caused CPIF SAF to distribute in kind an aggregate 1,182,595 shares of Common Stock to such limited partners for no consideration, in connection with their withdrawal from CPIF SAF.
Item 4.	Purpose of Transaction
	Item 4 of the Original Schedule 13D, as previously amended, is hereby amended by the addition of the following description of events involving the Reporting Persons and certain limited partners of CPIF SAF. The disclosure set forth in Item 3 above regarding the distribution of shares of Common Stock to certain limited partners in CPIF SAF is incorporated herein.
Item 5.	Interest in Securities of the Issuer
(a)	With respect to each Reporting Person, the information set forth in rows 11 and 13 of the applicable cover page is incorporated herein by reference.
(b)	With respect to each Reporting Person, the information set forth in rows 7-10 of the applicable cover page is incorporated herein by reference.
(c)	Not applicable.
(d)	Except for clients of Conversant Capital or another investment advisor subsidiary of Conversant Capital who may have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, Common Stock or Warrants, if any, held in managed accounts, no person other than the Reporting Persons are known by the Reporting Persons to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, any Common Stock or Warrants described in this Schedule 13D, other than indirect interests of investors in the Conversant Investors.
(e)	Not applicable.
Item 6.	Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer
	Item 6 is hereby amended by the addition of the following. The disclosure set forth in Item 3 above regarding the transfer of shares of Common Stock to certain limited partners in CPIF SAF is incorporated herein. Conversant Capital has a non-discretionary investment advisory relationship with, and an ongoing interest in the proceeds of the sale of distributed shares of Common Stock received by, one of the distributees, subject in respect of the latter to an agreed-upon hurdle rate.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Conversant Dallas Parkway (A) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Dallas Parkway (B) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Dallas Parkway (D) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Dallas Parkway (F) LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant GP Holdings LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant PIF Aggregator A LP

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant Private GP LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant GP Holdings LLC

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Capital LLC

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Conversant Private GP LLC

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

CPIF K Co-Invest SPT A, L.P.

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant Private GP LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

CPIF Sparti SAF, L.P.

Signature:	/s/ Paul Dumaine
Name/Title:	by: Conversant Private GP LLC, its general partner, By Paul Dumaine, General Counsel and Chief Compliance Officer
Date:	08/25/2026

Simanovsky Michael

Signature:	/s/ Paul Dumaine
Name/Title:	by: Paul Dumaine, Attorney-in-fact for Michael J. Simanovsky
Date:	08/25/2026